Project Grant HT94252510514
Award Date
9/15/25
Completion Date
9/14/29
Dollars Obligated
$1.3M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Irwindale, CA 91010, USA
Similar Awards
The Defense Health Agency awarded a $2,136,000.00 Project Grant to the Beckman Research Institute of the City of Hope under the Military Medical Research and Development program (CFDA 12.420) to conduct research on developmental therapeutics and potential treatments targeting RALBP1 for castration-resistant prostate carcinoma. The grant has a performance period from September 1, 2025 to August 31, 2028. As a renowned non-profit medical research organization, the Beckman Research Institute has an...
This Project Grant award of $1,759,998.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by the Beckman Research Institute of the City of Hope to potentiate T cell activity against multiple myeloma through inhibition of sumoylation. The research aims to transform healthcare for Service Members and the American public through innovative and impactful work. The award term runs from Aug 1, 2023 to Jul 31, 2026. As a...
The Defense Health Agency awarded a $800,643 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Beckman Research Institute of the City of Hope, a nonprofit medical research organization located in Duarte, California. The grant, awarded on June 1, 2025, with a final completion date of May 31, 2028, will support a research project titled "A ROLE OF PEPTIDYLARGININE DEIMINASES IN MEDIATING IMMUNE EVASION OF TRIPLE-NEGATIVE BREAST CANCER." The...
The Department of Defense's Defense Health Agency awarded a $447,612 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Beckman Research Institute of the City of Hope. The grant supports the development of a "highly tumor-specific oncolytic virus in combination with a viral protein-target T cell engager for the treatment of triple-negative breast cancer." The award period runs from January 1, 2024 to December 31, 2026. As a nonprofit...
The Defense Health Agency awarded a $5,339,958 Project Grant to the Beckman Research Institute of the City of Hope under the Military Medical Research and Development (CFDA 12.420) program. The grant supports the development of a digital health intervention for self-management and telemonitoring in chimeric antigen receptor (CAR)-T cell therapy. This 4-year research project, running from June 2025 to June 2029, aims to advance medical solutions for the battlefield and transform healthcare for...
The U.S. Defense Health Agency awarded a $177,992 Project Grant to the Beckman Research Institute of the City of Hope under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on Sep 1, 2025 with an ultimate completion date of Aug 31, 2027, will support the generation of novel tools for the development of targeted approaches for AL amyloidosis. As a renowned nonprofit medical research organization, the Beckman Research Institute will leverage its expertise...
This $615,999 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Beckman Research Institute of the City of Hope, a nonprofit organization. The grant funds research to develop a "Targeted Telomere-Disrupting Oligonucleotide for Acute Myeloid Leukemia Therapy" over a 3-year period from Sep 1, 2023 to Aug 31, 2026. As a nonprofit research organization, Beckman Research Institute leverages its medical...
This $1,175,982 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports a telehealth intervention aimed at improving quality of life and pancreatic cancer survivorship. The grant, awarded to the Beckman Research Institute of the City of Hope, a nonprofit research organization, will fund the development and implementation of this telehealth program over a 3-year period from August 2024 to July 2027. The project will leverage...
The Defense Health Agency (DHA) awarded a $999,997 project grant under the Military Medical Research and Development (CFDA 12.420) program to the Beckman Research Institute of the City of Hope for the "PERIOPERATIVE OSTOMY SELF-MANAGEMENT TELEHEALTH INTERVENTION FOR CANCER SURVIVORS" project. The grant, awarded on September 15, 2024, will fund research to develop a telehealth intervention to support self-management for cancer survivors with ostomies. As a nonprofit medical research...
The U.S. Defense Health Agency awarded a $1,056,000.00 Project Grant to the Beckman Research Institute of the City of Hope, a nonprofit organization, to conduct research on PP2A as a promising biomarker and therapeutic target in small cell lung cancer. The grant period runs from September 1, 2023 to August 31, 2026 under the Military Medical Research and Development program (CFDA 12.420). The Beckman Research Institute, which has prior experience collaborating on federal health research...